VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

BioLoomics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 88 out of 100

Evolving spatially programmable antibody degraders.

Also known as BioLoomics, Inc.

  • Biotech & therapeutics
Status
Operatingas of 2026-09-23
Business model
B2B
Legal name
BioLoomics, Inc.
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Evolving spatially programmable antibody degraders.

Funding snapshot

Total raised
$11MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round
Round, $450K2025-08-11

Funding rounds

Round, 2025
$450K2025-08-11, SEC form D sold, 5 investors
Round, 2023
$9.3M2023-02-24, SEC form D sold, 23 investors
Round, 2021
$575K2021-05-11, SEC form D sold, 11 investors
Round, 2019
$600K2019-05-30, SEC form D sold, 8 investors
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy